评价项目

观察组30例

对照组30例

治疗前

治疗后

治疗前

治疗后

PF

15.21 ± 3.13

20.56 ± 2.32*#

15.18 ± 3.20

18.34 ± 2.56*

RP

4.19 ± 0.41

5.91 ± 0.22*#

4.23 ± 0.36

5.89 ± 0.25*

SF

4.33 ± 1.71

6.32 ± 1.68*#

4.36 ± 1.69

5.45 ± 1.37*

BP

3.79 ± 1.15

5.28 ± 1.3*#

3.82 ± 1.19

4.31 ± 1.37*

MH

9.61 ± 2.18

14.62 ± 1.53*#

9.56 ± 2.23

10.79 ± 1.81*

RE

3.89 ± 0.56

5.31 ± 0.46*#

3.93 ± 0.56

4.65 ± 0.39*

VT

8.78 ± 2.34

11.33 ± 1.89*#

8.75 ± 2.31

9.96 ± 1.65*

GH

8.83 ± 1.23

13.35 ± 0.89*#

8.78 ± 1.34

10.13 ± 0.86*